“Botanicals Market Report is set to have rapid growth due to increased consumer awareness for preventive healthcare, aging population, increasing prevalence of chronic problems, assurance of no side effects at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Botanicals Market Forecast 2019-2029: By Intervention (Ayurveda, Naturopathy & Homeopathy), By Distribution Channel (Direct Sales, E-commerce), By Region And Segment Forecasts.
For centuries, natural products, extracts and natural products have been used as a form of treatment for various acute and chronic disorders. Over time, various improvements have been made to natural products that have led to a correct dosage and properties from raw forms and are now classified under the name of botanical products / herbal supplements / natural supplements.
Botanical products on the market are available in various forms including oils, tablets, herbs, powders. Even in this advanced age, botanical products are widely used by almost all population groups ranging from newborns, youngsters and adults. People are adopting botanical products for almost all types of ailments such as dietary supplements for chronic pain and injury treatment. Greater consumer awareness for preventive health care together with an aging population, an increase in the prevalence of chronic problems such as cardiovascular disease, diabetes, obesity, and a greater belief that there are no side effects unlike modern medicine were the main ones factors that have contributed to the growth of the market.
Leading companies featured in the report include Dabur, Ricola, Herbalife, Himalaya, Omega Protein Corp., Amway, Bayer AG, Naturalife Asia Co., Bio-Botanica Inc. and Nature's Bounty Co.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.